会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Silver-dispersing polypeptides
    • 银分散多肽
    • US07179885B2
    • 2007-02-20
    • US10451897
    • 2001-12-21
    • Jan Bastiaan BouwstraGertjan BögelsYuzo Toda
    • Jan Bastiaan BouwstraGertjan BögelsYuzo Toda
    • C07K14/78G03C1/005G03C1/047
    • C07K14/78G03C1/0051G03C1/047
    • Silver halide emulsions for photographic uses contain a nucleation peptiser having at least one region A of up to 100 amino acids. Region A can either consist of (i) at least two silver-binding amino acids and up to 98 amino acids between the two silver-binding amino acids, or can consist of (ii) a stretch of from 9 to 100 amino acids having a polarity corresponding to an average transfer free energy ΔF equal to or higher than +1.0 kcal/mol. The nucleation peptizer also has at least one region B (separated from region A) having at least 50 amino acids and having a polarity corresponding to an average transfer free energy equal to or lower than −1.0 kcal/mol and not containing methionine residues. The emulsion may also contain a growth peptiser having similar characteristics to the nucleation peptiser, but having a longer A region and a greater overall length.
    • 用于照相用途的卤化银乳剂含有具有至多一个至多100个氨基酸的区域A的成核胶溶剂。 区域A可以由(i)至少两个结合银的氨基酸和两个结合银的氨基酸之间的至多98个氨基酸组成,或者可以由(ii)具有9至100个氨基酸的片段组成,其具有 对应于等于或高于+1.0kcal / mol的平均转移自由能ΔF的极性。 成核胶溶剂还具有至少一个具有至少50个氨基酸并具有对应于等于或低于-1.0kcal / mol的平均转移自由能的极性并且不含有甲硫氨酸残基的至少一个区域B(与区域A分离)。 该乳液还可含有具有与成核胶溶剂相似的特征但具有较长A区和更长总长的生长胶溶剂。
    • 3. 发明授权
    • Method for prevention of platelet aggregation employing and RGD-enriched gelatine-like protein
    • 防止使用富含RGD的明胶样蛋白的血小板聚集的方法
    • US08080515B2
    • 2011-12-20
    • US12494450
    • 2009-06-30
    • Jan Bastiaan BouwstraAndries Johannes Jozef Van EsYuzo Toda
    • Jan Bastiaan BouwstraAndries Johannes Jozef Van EsYuzo Toda
    • C07K14/00
    • A61K9/5078A61K9/1658A61K47/42C07K14/78C12N5/0075C12N2533/30C12N2533/54
    • The invention concerns a cell support comprising an RGD-enriched gelatine that has a more even distribution of RGD sequences than occurring in a natural gelatine and with a minimum level of RGD sequences. More precise the percentage of RGD sequences related to the total number of amino acids is at least 0.4 and if the RGD-enriched gelatine comprises 350 amino acids or more, each stretch of 350 amino acids contains at least one RGD motif. Preferably the RGD-enriched gelatines are prepared by recombinant technology, and have a sequence that is derived from a human gelatine or collagen amino acid sequence. The invention also relates to RGD-enriched gelatines that are used for attachment to integrins. In particular The RGD-enriched gelatines of the invention are suitable for coating a cell culture support for growing anchor-dependant cell types. Further, the RGD-enriched gelatines of the invention may find use in medical applications, in particular as a coating on implant or transplant material or as a component of drug delivery systems.
    • 本发明涉及包含富含RGD的明胶的细胞支持物,其具有比在天然明胶中发生的RGD序列更均匀的分布并具有最低水平的RGD序列。 更准确地说,与氨基酸总数相关的RGD序列的百分比至少为0.4,并且如果RGD富集的明胶包含350个氨基酸或更多个,则每个拉伸的350个氨基酸含有至少一个RGD基序。 优选地,通过重组技术制备富含RGD的明胶,并且具有源自人明胶或胶原氨基酸序列的序列。 本发明还涉及用于与整联蛋白连接的RGD富集的明胶。 特别地,本发明的RGD富集的明胶适用于涂覆细胞培养支持物,用于生长锚依赖细胞类型。 此外,本发明的富含RGD的明胶可用于医学应用,特别是作为植入物或移植材料上的涂层或药物递送系统的组分。
    • 4. 发明授权
    • RGD-enriched gelatine-like proteins with enhanced cell binding
    • 具有增强的细胞结合的RGD富集的明胶样蛋白质
    • US07671016B2
    • 2010-03-02
    • US11770271
    • 2007-06-28
    • Jan Bastiaan BouwstraAndries Johannes Jozef Van EsYuzo Toda
    • Jan Bastiaan BouwstraAndries Johannes Jozef Van EsYuzo Toda
    • C07K14/00
    • A61K9/5078A61K9/1658A61K47/42C07K14/78C12N5/0075C12N2533/30C12N2533/54
    • The invention concerns a cell support comprising an RGD-enriched gelatine that has a more even distribution of RGD sequences than occurring in a natural gelatine and with a minimum level of RGD sequences. More precise the percentage of RGD sequences related to the total number of amino acids is at least 0.4 and if the RGD-enriched gelatine comprises 350 amino acids or more, each stretch of 350 amino acids contains at least one RGD motif. Preferably the RGD-enriched gelatines are prepared by recombinant technology, and have a sequence that is derived from a human gelatine or collagen amino acid sequence. The invention also relates to RGD-enriched gelatines that are used for attachment to integrins. In particular The RGD-enriched gelatines of the invention are suitable for coating a cell culture support for growing anchor-dependant cell types. Further, the RGD-enriched gelatines of the invention may find use in medical applications, in particular as a coating on implant or transplant material or as a component of drug delivery systems.
    • 本发明涉及包含富含RGD的明胶的细胞支持物,其具有比在天然明胶中发生的RGD序列更均匀的分布并具有最低水平的RGD序列。 更准确地说,与氨基酸总数相关的RGD序列的百分比至少为0.4,并且如果RGD富集的明胶包含350个氨基酸或更多个,则每个拉伸的350个氨基酸含有至少一个RGD基序。 优选地,通过重组技术制备富含RGD的明胶,并且具有源自人明胶或胶原氨基酸序列的序列。 本发明还涉及用于与整联蛋白连接的RGD富集的明胶。 特别地,本发明的RGD富集的明胶适用于涂覆细胞培养支持物,用于生长锚依赖细胞类型。 此外,本发明的富含RGD的明胶可用于医学应用,特别是作为植入物或移植材料上的涂层或药物递送系统的组分。
    • 6. 发明授权
    • Drug delivery system comprising an RGD-enriched gelatine
    • 药物递送系统包含富含RGD的明胶
    • US07645737B2
    • 2010-01-12
    • US11770197
    • 2007-06-28
    • Jan Bastiaan BouwstraAndries Johannes Jozef Van EsYuzo Toda
    • Jan Bastiaan BouwstraAndries Johannes Jozef Van EsYuzo Toda
    • C07K14/00
    • A61K9/5078A61K9/1658A61K47/42C07K14/78C12N5/0075C12N2533/30C12N2533/54
    • The invention concerns a cell support comprising an RGD-enriched gelatine that has a more even distribution of RGD sequences than occurring in a natural gelatine and with a minimum level of RGD sequences. More precise the percentage of RGD sequences related to the total number of amino acids is at least 0.4 and if the RGD-enriched gelatine comprises 350 amino acids or more, each stretch of 350 amino acids contains at least one RGD motif. Preferably the RGD-enriched gelatines are prepared by recombinant technology, and have a sequence that is derived from a human gelatine or collagen amino acid sequence. The invention also relates to RGD-enriched gelatines that are used for attachment to integrins. In particular The RGD-enriched gelatines of the invention are suitable for coating a cell culture support for growing anchor-dependant cell types. Further, the RGD-enriched gelatines of the invention may find use in medical applications, in particular as a coating on implant or transplant material or as a component of drug delivery systems.
    • 本发明涉及包含富含RGD的明胶的细胞支持物,其具有比在天然明胶中发生的RGD序列更均匀的分布并具有最低水平的RGD序列。 更准确地说,与氨基酸总数相关的RGD序列的百分比至少为0.4,并且如果RGD富集的明胶包含350个氨基酸或更多个,则每个拉伸的350个氨基酸含有至少一个RGD基序。 优选地,通过重组技术制备富含RGD的明胶,并且具有源自人明胶或胶原氨基酸序列的序列。 本发明还涉及用于与整联蛋白连接的RGD富集的明胶。 特别地,本发明的RGD富集的明胶适用于涂覆细胞培养支持物,用于生长锚依赖细胞类型。 此外,本发明的富含RGD的明胶可用于医学应用,特别是作为植入物或移植材料上的涂层或药物递送系统的组分。
    • 9. 发明授权
    • RGD-enriched gelatines
    • 富含RGD的明胶
    • US07598347B2
    • 2009-10-06
    • US11770019
    • 2007-06-28
    • Jan Bastiaan BouwstraAndries Johannes Jozef Van EsYuzo Toda
    • Jan Bastiaan BouwstraAndries Johannes Jozef Van EsYuzo Toda
    • C07K14/00
    • A61K9/5078A61K9/1658A61K47/42C07K14/78C12N5/0075C12N2533/30C12N2533/54
    • The invention concerns a cell support comprising an RGD-enriched gelatine that has a more even distribution of RGD sequences than occurring in a natural gelatine and with a minimum level of RGD sequences. More precise the percentage of RGD sequences related to the total number of amino acids is at least 0.4 and if the RGD-enriched gelatine comprises 350 amino acids or more, each stretch of 350 amino acids contains at least one RGD motif. Preferably the RGD-enriched gelatines are prepared by recombinant technology, and have a sequence that is derived from a human gelatine or collagen amino acid sequence. The invention also relates to RGD-enriched gelatines that are used for attachment to integrins. In particular The RGD-enriched gelatines of the invention are suitable for coating a cell culture support for growing anchor-dependant cell types. Further, the RGD-enriched gelatines of the invention may find use in medical applications, in particular as a coating on implant or transplant material or as a component of drug delivery systems.
    • 本发明涉及包含富含RGD的明胶的细胞支持物,其具有比在天然明胶中发生的RGD序列更均匀的分布并具有最低水平的RGD序列。 更准确地说,与氨基酸总数相关的RGD序列的百分比至少为0.4,并且如果RGD富集的明胶包含350个氨基酸或更多个,则每个拉伸的350个氨基酸含有至少一个RGD基序。 优选地,通过重组技术制备富含RGD的明胶,并且具有源自人明胶或胶原氨基酸序列的序列。 本发明还涉及用于与整联蛋白连接的RGD富集的明胶。 特别地,本发明的RGD富集的明胶适用于涂覆细胞培养支持物,用于生长锚依赖细胞类型。 此外,本发明的富含RGD的明胶可用于医学应用,特别是作为植入物或移植材料上的涂层或药物递送系统的组分。
    • 10. 发明授权
    • RGD-enriched gelatine-like proteins with enhanced cell binding
    • 具有增强的细胞结合的RGD富集的明胶样蛋白质
    • US07560427B2
    • 2009-07-14
    • US11770256
    • 2007-06-28
    • Jan Bastiaan BouwstraAndries Johannes Jozef Van EsYuzo Toda
    • Jan Bastiaan BouwstraAndries Johannes Jozef Van EsYuzo Toda
    • C07K14/00
    • A61K9/5078A61K9/1658A61K47/42C07K14/78C12N5/0075C12N2533/30C12N2533/54
    • The invention concerns a cell support comprising an RGD-enriched gelatine that has a more even distribution of RGD sequences than occurring in a natural gelatine and with a minimum level of RGD sequences. More precise the percentage of RGD sequences related to the total number of amino acids is at least 0.4 and if the RGD-enriched gelatine comprises 350 amino acids or more, each stretch of 350 amino acids contains at least one RGD motif. Preferably the RGD-enriched gelatines are prepared by recombinant technology, and have a sequence that is derived from a human gelatine or collagen amino acid sequence. The invention also relates to RGD-enriched gelatines that are used for attachment to integrins. In particular The RGD-enriched gelatines of the invention are suitable for coating a cell culture support for growing anchor-dependant cell types. Further, the RGD-enriched gelatines of the invention may find use in medical applications, in particular as a coating on implant or transplant material or as a component of drug delivery systems.
    • 本发明涉及包含富含RGD的明胶的细胞支持物,其具有比在天然明胶中发生的RGD序列更均匀的分布并具有最低水平的RGD序列。 更准确地说,与氨基酸总数相关的RGD序列的百分比至少为0.4,并且如果RGD富集的明胶包含350个氨基酸或更多个,则每个拉伸的350个氨基酸含有至少一个RGD基序。 优选地,通过重组技术制备富含RGD的明胶,并且具有源自人明胶或胶原氨基酸序列的序列。 本发明还涉及用于与整联蛋白连接的RGD富集的明胶。 特别地,本发明的RGD富集的明胶适用于涂覆细胞培养支持物,用于生长锚依赖细胞类型。 此外,本发明的富含RGD的明胶可用于医学应用,特别是作为植入物或移植材料上的涂层或药物递送系统的组分。